| HOME >> BIOLOGY >> TECHNOLOGY |
Interest income 112,000 51,000 335,000 195,000
Minority interest
in joint venture - (2,000) 6,000 (3,000)
Other income - - 25,000 0
112,000 49,000 366,000 192,000
Net loss ($8,000) ($23,000) ($62,000) ($216,000)
Net loss per share -
basic ($0.00) ($0.00) ($0.00) ($0.01)
Net loss per share -
diluted ($0.00) ($0.00) ($0.00) ($0.01)
Weighted average
common shares
outstanding - basic 16,979,623 16,999,623 16,967,504 16,998,820
Weighted average
common shares
outstanding -
diluted 16,979,623 16,999,623 16,967,504 16,998,820
CONDENSED BALANCE SHEET
(Unaudited)
December 31, September 30,
2007 2008
Cash and marketable securities $8,804,000 $8,591,000
Other current assets 167,000 154,000
Total assets $8,971,000 $8,745,000
Current liabilities $128,000 $129,000
Minority interest in joint venture 11,000 24,000
Total stockholders' equity 8,832,000 8,592,000
Total liabilities and equity $8,971,000 $8,745,000
| SOURCE AutoImmune Inc. Copyright©2008 PR Newswire. All rights reserved |